Renal-cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes

International Journal of Cancer

Volumn 68, Issue 2, 1996, Pages 177-182

  Brouwenstijn, Nathalie ^a   Gaugler, Béatrice ^b   Krüse, K Margaretha ^a   Van der Spek, Corry W ^a   Mulder, Arend ^a   Osanto, Susanne ^a   Van den Eynde, Benoît J ^b   Schrier, Peter I ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ARTICLE; BLOOD CELL; CASE REPORT; CELL CLONE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE;

CARCINOMA, RENAL CELL; CROSS REACTIONS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; HUMANS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; KIDNEY NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0029798212     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961009)68:2<177::AID-IJC6>3.0.CO;2-V     Document Type: Article

References (21)

1. ALEXANDER, J.P., KUDOH, S., MELSOP, K.A., HAMILTON, T.A., EDINGER, M.G., TUBES, R.R., SICA, D., TUASON, L., KLEIN, E., BUKOWSKI, R.M. and FINKE, J.H., T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res., 53, 1380-1387 (1993).
2. BERGER, A.E., DAVIS, J.E. and CRESSWELL, P., Monoclonal antibody to HLA-A3. Hybridoma, 1, 87-90 (1982).
3. BERNHARD, H., KARBACH, J., WÖLFEL, T., BUSCH, P., STORKEL, S., HUBER, C., WÖLFEL, C., SELIGER, B., MEYER ZUM BUESCHENFELDE, K.H. and KNUTH, A., Cellular immune response to human renal cell carcinomas: definition of a common antigen recognized by HLA-A2 restricted cytotoxic T lymphocyte (CTL) clones. Int. J. Cancer, 59, 837-842 (1994).
4. DÉTRISAC, C.J., SENS, M.A., GARVIN, A.J., SPICER, S.S. and SENS, D.A., Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int., 25, 383-390 (1984).
5. ELLIS, S.A., TAYLOR, C. and MCMICHAEL, A., Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum. Immunol., 5, 49-59 (1982).
6. + T cell line. J. Immunother., 11, 1-11 (1992).
7. FINKE, J.H., ZEA, A.M., STANLEY, J., LONGO, D.L., MIZOGUCHI. H., TUBBS, R.R., WILTROUT, R.H., O'SHEA, J.J., KUDOH, S., KLEIN, E., BUKOWSKI, R.M. and OCHOA, A.C., Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Key, 53, 5613-5616 (1993).
8. FISCHER, P., STORKEL, S., HAASE, W. and SCHERBERICH, J.E., Differential diagnosis of histogenetically distinct human epithelial renal tumours with a monoclonal antibody against γ-glutamyltransferase. Cancer Immunol. Immunother, 33, 382-388 (1991).
9. HÉRIN, M., LEMOINE, C., WEYNANTS, P., VESSIÈRE, F., VAN PEL, A., KNUTH, A., DEVOS, R. and BOON, T., Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int. J. Cancer, 39, 390-396 (1987).
10. KAWAKAMI, Y., ZAKUT, R., TOPALIAN, S.L., STOTTER, H. and ROSENBERG, S.A., Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J. Immunol., 148, 638-643 (1992).
11. KOO, A.S., TSO, C.L., SHIMABUKURO, T., PEYRET, C., DEKERNION, J.B. and BELLDEGRUN, A., Autologous tumor-specific cytotoxicity of tumor-infiltrating lymphocytes derived from human renal cell carcinoma. J. Immunother., 10, 347-354 (1991).
12. LINEMAN, W.M., WALTHER, M.M., ALEXANDER, R.B. and ROSENBERG, S.A., Adoptive immunotherapy of renal cell carcinoma: studies from the Surgery Branch, National Cancer Institute [Review]. Semin. Urol., 11, 41-43 (1993).
13. MORITA, T., SALMERON, M.A., HAYAKAWA, K., SWANSON, D.A., VON ESCHENBACH, A.C. and ITOH, K., T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma. Reg. Immunol., 4, 225-235 (1992).
14. REBAI, N. and MALISSEN, B., Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens, 22, 107-117 (1983).
15. ROHREN, E.M., MCCORMICK, D.J. and PEASE, L.R., Peptide-induced conformational changes in class I molecules. Direct detection by flow cytometry. J. Immunol., 152, 5337-5343 (1994).
16. ROSENBERG, S.A., LOTZE, M.T., YANG, J.C., AEBERSOLD, P.M., LINEMAN, W.M., SEIPP, C.A. and WHITE, D.E., Experience with the use of high-dose interleukin-2 in the treatment of 552 cancer patients. Ann. Surg., 210, 474-484 (1989).
17. SCHENDEL, D.J., GANSBACHER, B., OBERNEDER, R., KRIEGMAIR, M., HOFSTETTER, A., RIETHMULLER, G. and SEGURADO, O.G., Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J. Immunol., 151, 4209-4220 (1993).
18. SICA, D., RAYMAN, P., STANLEY, J., EDINGER, M., TUBBS, R.R., KLEIN, E., BUKOWSKI, R. and FINKE, J.H., Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma. Int. J. Cancer, 53, 941-947 (1993).
19. VAN DEN EYNDE, B. and BRICHARD, V.G., New tumor antigens recognized by T cells. Curr. Opin. Immunol., 7, 674-681 (1995).
20. WÖLFEL, T., KLEHMANN, E., MULLER, C., SCHUTT, K.H., MEYER ZUM BUSCHENFELDE, K.H. and KNUTH, A., Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J exp. Med., 170, 797-810 (1989).
21. YANG, S.Y., MORISHIMA, Y., COLLINS, N.H., ALTON, T., POLLACK, M.S., YUNIS, E.J. and DUPONT, B., Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes. Immunogenetics, 19, 217-231 (1984).